Product Program year 2022 Source: CMS Open Payments

Viroseq

Device Molecular Diagnostics

PDI 00884999039278

Open in the dashboard

General payments

$12,798

4 payments

Research payments

$0

0 payments

Through program year 2022, $12,798 in general payments and $0 in research payments were reported against Viroseq (Molecular Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2022 General $12,798 4

Breakdown

Who paid General payments · program year 2022
  1. Abbott Laboratories $12,798 4 payments
Top recipients General payments · program year 2022
  1. Larissa May Emergency Medicine · Washington, DC $3,750 29% · 1 payment
  2. Stanford Shulman Pediatric Infectious Diseases · Chicago, IL $3,188 25% · 1 payment
  3. Maurice Allgeier Pediatrics · Louisville, KY $3,161 25% · 1 payment
  4. Antonio Anzueto Pulmonary Disease · San Antonio, TX $2,700 21% · 1 payment

Each share is of general payments naming this product in 2022.

Specialties paid General payments · program year 2022
  1. Emergency Medicine $3,750 29% · 1 practitioner
  2. Pediatric Infectious Diseases Pediatrics $3,188 25% · 1 practitioner
  3. Pediatrics $3,161 25% · 1 practitioner
  4. Pulmonary Disease Internal Medicine $2,700 21% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2022
  1. District of Columbia $3,750 29% · 1 recipient
  2. Illinois $3,188 25% · 1 recipient
  3. Kentucky $3,161 25% · 1 recipient
  4. Texas $2,700 21% · 1 recipient

Each share is of general payments naming this product in 2022 where a state was reported.

4 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record